Morten Schou

12.5k total citations · 1 hit paper
188 papers, 4.0k citations indexed

About

Morten Schou is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Morten Schou has authored 188 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Cardiology and Cardiovascular Medicine, 54 papers in Endocrinology, Diabetes and Metabolism and 31 papers in Surgery. Recurrent topics in Morten Schou's work include Heart Failure Treatment and Management (75 papers), Cardiovascular Function and Risk Factors (54 papers) and Diabetes Treatment and Management (37 papers). Morten Schou is often cited by papers focused on Heart Failure Treatment and Management (75 papers), Cardiovascular Function and Risk Factors (54 papers) and Diabetes Treatment and Management (37 papers). Morten Schou collaborates with scholars based in Denmark, United States and United Kingdom. Morten Schou's co-authors include Finn Gustafsson, Caroline Kistorp, Per Hildebrandt, Lars Køber, Christian Torp‐Pedersen, Lars Videbæk, Gunnar Gislason, Jacob Eifer Møller, Jon Rasmussen and Jens Faber and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Morten Schou

168 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial

2016 381 citations Caroline Kistorp, Pernille Holmager et al. European Journal of Heart Failure profile →

Peers

Countries citing papers authored by Morten Schou

Since Specialization

Citations

This map shows the geographic impact of Morten Schou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Schou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Schou more than expected).

Fields of papers citing papers by Morten Schou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Schou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Schou. The network helps show where Morten Schou may publish in the future.

Co-authorship network of co-authors of Morten Schou

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Schou. A scholar is included among the top collaborators of Morten Schou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Schou. Morten Schou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dapagliflozin versus empagliflozin and major adverse cardiovascular events in type 2 diabetes: a nationwide cohort study 2024 ·European Heart Journal ·(unknown), Lars Køber, (unknown), (unknown), Nadia Dridi, (unknown), Morten Schou, (unknown), Peter Rossing, Emil Loldrup Fosbøl, Jawad H. Butt	1
2	1893P Incidence of myocardial ischemia during treatment with capecitabine: Assessment with Holter recording and cardiac biomarkers 2024 ·Annals of Oncology ·Anne Dyhl-Polk, Morten Schou, Kirsten Vistisen, (unknown), Stig E. Bojesen, (unknown), Merete Vaage‐Nilsen, Dorte Nielsen	0
3	Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study 2024 ·European Heart Journal ·Anders Holt, (unknown), Jarl Emanuel Strange, (unknown), Anne-Marie Schjerning, Peter Rasmussen, Christian Torp‐Pedersen, Gunnar Gislason, Morten Schou, Patricia McGettigan, Morten Lamberts	16
4	Driving restrictions following defibrillator implantation: a nationwide register-linked survey study on the impact on employment, daily living, and driving behaviour 2024 ·European Heart Journal - Quality of Care and Clinical Outcomes ·(unknown), Trine Bernholdt Rasmussen, Signe Stelling Risom, (unknown), Morten Schou, (unknown), Gunnar Gislason, Anne‐Christine Ruwald, (unknown)	0
5	Long-term rate of ventricular arrhythmia in autoimmune disease 2024 ·European Journal of Preventive Cardiology ·Guoli Sun, Emil Loldrup Fosbøl, Morten Schou, Mikkel Faurschou, Adelina Yafasova, Jeppe Kofoed Petersen, Ketil Haugan, Ulrik M. Mogensen, Jesper Hastrup Svendsen, Lars Køber, Jawad H. Butt	1
6	The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes 2023 ·Diabetes Obesity and Metabolism ·(unknown), Morten Schou, Philip Hasbak, Andreas Kjær, Emil Wolsk, Bo Zerahn, Niels Brandt, Peter Gæde, Peter Rossing, Jens Faber, Silvio E. Inzucchi, Finn Gustafsson, Caroline Kistorp	9
7	Impact of Acute Kidney Injury After Transcatheter Aortic Valve Replacement: A Nationwide Study 2023 ·Journal of the American Heart Association ·Jeppe Kofoed Petersen, Lauge Østergaard, Nicholas Carlson, (unknown), Jarl Emanuel Strange, Morten Schou, Lars Køber, Emil Loldrup Fosbøl	2
8	Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial 2022 ·Circulation Heart Failure ·Henning Bundgaard, Anna Axelsson Raja, Kasper Iversen, Nana Valeur, Niels Tønder, Morten Schou, Alex Hørby Christensen, Niels Eske Bruun, Helle Søholm, (unknown), N. Fry, Elisha J. Hamilton, Søren Boesgaard, (unknown), Emil Wolsk, Kasper Rossing, Lars Køber, H Rasmussen, Christoffer Rasmus Vissing	14
9	Immediate evaluation of global longitudinal strain at initiation of trastuzumab treatment in breast cancer patients 2021 ·Echocardiography ·Ann Banke, Morten Schou, Marianne Ewertz, Jordi Sanchez Dahl, Peter Frederiksen, Lars Videbæk, Søren Cold, Jacob Eifer Møller	3
10	Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial 2021 ·Journal of the American Heart Association ·(unknown), Morten Schou, Philip Hasbak, Andreas Kjær, Emil Wolsk, Bo Zerahn, (unknown), Niels Brandt, Peter Gæde, Peter Rossing, Jens Faber, Silvio E. Inzucchi, Finn Gustafsson, Caroline Kistorp	22
11	Catheter ablation for atrial fibrillation is associated with lower incidence of heart failure and death 2019 ·EP Europace ·Daniel Modin, Brian Claggett, Gunnar Gislason, Morten Lock Hansen, René Worck, Arne Johannessen, Jim Hansen, Jesper Hastrup Svendsen, Jannik Langtved Pallisgaard, Morten Schou, Lars Køber, Scott D. Solomon, Christian Torp‐Pedersen, Tor Biering‐Sørensen	9
12	Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve 2017 ·BMC Cardiovascular Disorders ·Pernille Holmager, Michael Egstrup, Finn Gustafsson, Morten Schou, Jordi Sanchez Dahl, Lars Melholt Rasmussen, Jacob Eifer Møller, Christian Tuxen, Jens Faber, Caroline Kistorp	16
13	Effect of Extended Follow-Up in a Specialized Heart Failure Clinic on Adherence to Guideline Recommended Therapy: NorthStar Adherence Study 2014 ·European Journal of Heart Failure ·Morten Schou, Gunnar Gislason, Lars Videbæk, Lars Køber, Christian Tuxen, Christian Torp‐Pedersen, Per Hildebrandt, Finn Gustafsson	19
14	Adding Serial N-Terminal Pro Brain Natriuretic Peptide Measurements to Optimal Clinical Management in Outpatients with Systolic Heart Failure: A Multicentre Randomized Clinical Trial (NorthStar Monitoring Study) 2013 ·European Journal of Heart Failure ·Morten Schou, Finn Gustafsson, Lars Videbæk, Helge Andersen, (unknown), Ole Nyvad, (unknown), Lars Fog, (unknown), Olav Wendelboe Nielsen, (unknown), Jawdat Abdulla, Per Hildebrandt	30
15	Patient Adherence to Evidence-Based Pharmacotherapy in Systolic Heart Failure and the Transition of Follow-Up from Specialized Heart Failure Outpatient Clinics to Primary Care 2013 ·European Journal of Heart Failure ·(unknown), Morten Schou, Christian Torp‐Pedersen, Lars Køber, Finn Gustafsson, Per Hildebrandt, Lars Videbæk, Henrik Wiggers, (unknown), Mette Charlot, Gunnar Gislason	35
16	α-Defensins and Outcome in Patients with Chronic Heart Failure 2012 ·European Journal of Heart Failure ·(unknown), Jan Frystyk, Jens Faber, Morten Schou, Allan Flyvbjerg, Per Hildebrandt, Ilan Raymond, Tobias Wirenfeldt Klausen, Caroline Kistorp	22
17	Prevalence and Prognostic Significance of Hyponatraemia in Outpatients with Chronic Heart Failure 2011 ·European Journal of Heart Failure ·Louise Balling, Morten Schou, Lars Videbæk, Per Hildebrandt, Henrik Wiggers, Finn Gustafsson	65
18	Incidence and Predictors of Hospitalization or Death in Patients Managed in Multidisciplinary Heart Failure Clinics 2009 ·European Journal of Heart Failure ·Finn Gustafsson, Morten Schou, Lars Videbæk, Nadia Dridi, (unknown), (unknown), Per Hildebrandt	18
19	Treatment with Beta-Blockers in Nurse-Led Heart Failure Clinics: Titration Efficacy and Predictors of Failure 2007 ·European Journal of Heart Failure ·Finn Gustafsson, Morten Schou, Lars Videbæk, Tonny Nielsen, (unknown), John Markenvard, Tage Lysbo Svendsen, (unknown), (unknown), Per Hildebrandt	30
20	Unexplained Week-to-Week Variation in BNP and NT-proBNP is Low in Chronic Heart Failure Patients During Steady State 2006 ·European Journal of Heart Failure ·Morten Schou, Finn Gustafsson, Per Hostrup Nielsen, Lene Helleskov Madsen, Andreas Kjær, Per Hildebrandt	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact